| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/19/2009 | US20090074897 Agent for elevating adiponectin concentration |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples |
| 03/19/2009 | CA2699630A1 Transdermal, alcohol-free, pharmaceutical compositions |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036574A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 03/18/2009 | EP2036557A1 Antitumor agent for thyroid cancer |
| 03/18/2009 | EP2035419A1 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists |
| 03/18/2009 | EP2035377A1 Indole derivatives and their use as thyroid receptor ligands |
| 03/18/2009 | EP1569936B1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 03/18/2009 | EP1448993B1 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules |
| 03/18/2009 | CN101385846A Preparation method of Jiawei Xiaoyao power preparation |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CA2639640A1 Local vascular delivery of mtor inhibitors in combination with peroxisome proliferators-activated receptor stimulators |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/12/2009 | WO2009031943A1 Method for monitoring diabetes insulin therapy |
| 03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031708A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2008151746A3 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 03/12/2009 | US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 03/12/2009 | US20090069347 2-phenoxy pyrimidinone analogues |
| 03/12/2009 | US20090069240 Method of preventing and treating endocrine system disturbances |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2033634A1 Agent for increasing testosterone level |
| 03/11/2009 | EP1879580B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 03/11/2009 | EP1611111B1 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1294384B1 Use of lanthanum compounds for the treatment of bone diseases |
| 03/11/2009 | CN101384555A Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 03/11/2009 | CN100467601C PIM-3 kinase as a target for type 2 diabetes mellitus |
| 03/11/2009 | CN100467448C Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467058C Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 03/10/2009 | US7501515 Purified compound exhibits a melting endotherm with a peak temperature of about 262 degrees C. and an exotherm at about 253 degrees C.; solvent purification; useful in treating acne, female hirsutism and particularly benign prostatic hyperplasia |
| 03/10/2009 | US7501511 Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501116 Placental alkaline phosphatase to control diabetes |
| 03/05/2009 | WO2009028543A1 Substituted pyrazole derivative |
| 03/05/2009 | WO2009027994A2 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009027482A2 Tsh receptor antagonizing tetrahydroquinoline compounds |
| 03/05/2009 | WO2009027107A1 Inositol pyrophosphates determine exocytotic capacity |
| 03/05/2009 | WO2009026614A1 Hypoglycaemic tripeptide and methods of use thereof |
| 03/05/2009 | WO2009007454A3 8-beta-substituted estratrienes as selectively active estrogens |
| 03/05/2009 | WO2008088935A3 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 03/05/2009 | US20090062401 Decaline-derived compounds as pharmaceutically active agents |
| 03/05/2009 | US20090060982 Methods and devices for the sustained release of multiple drugs |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
| 03/05/2009 | CA2695503A1 Tsh receptor antagonizing tetrahydroquinoline compounds |
| 03/04/2009 | EP2030625A1 Use |
| 03/04/2009 | EP2029141A2 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |
| 03/04/2009 | EP2029124A1 Use of gpcr agonists to delay progression of diabetes |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN101375714A Pollen salt |
| 03/03/2009 | US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 03/03/2009 | CA2335551C Thyroid hormone analogues and methods for their preparation |
| 03/03/2009 | CA2324904C Topical hormonal composition with systemic effect |
| 02/26/2009 | WO2009026265A1 A method of extending the dose range of vitamin d compounds |
| 02/26/2009 | WO2009025792A2 Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof |
| 02/26/2009 | WO2009024797A1 Glucagon formulations |
| 02/26/2009 | WO2009024795A1 Acid containing lipid formulations |
| 02/26/2009 | WO2009024015A1 A stable formulation of exenatide |
| 02/26/2009 | WO2005067898A3 Improved sustained release compositions for pulmonary administration of insulin |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054417 Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 02/26/2009 | US20090054400 New progesterone receptor modulators |
| 02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | CA2697079A1 A method of extending the dose range of vitamin d compounds |
| 02/26/2009 | CA2697034A1 Acid containing lipid formulations |
| 02/26/2009 | CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/25/2009 | EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof |
| 02/25/2009 | EP2027870A1 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin |
| 02/25/2009 | EP2027141A1 11beta-benzaldoxime derivatives of d-homooestra-4,9-dien-3-ones |
| 02/25/2009 | EP2026799A2 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 02/25/2009 | EP1578726B1 Tetrahydroquinoline derivatives |
| 02/25/2009 | EP1254106B1 Calcilytic compounds |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN100463672C Method for preparing large quantity of micro-capsule |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |